Biotech Values

[jbog]

Why would anyone want to own MYL in the next year or so (unless you think they will get FDA approval for generic Copaxone)? After the ‘spinversion’ (#msg-107440341), ABT will own 22% of MYL and plans to divest its MYL shares fairly quickly, which will put a lot of pressure on MYL’s share price.

Nice 40% return in 6 months.